摘要
[Objective]Observed SMI valsartan combined with Western medicine treatment of chronic congestive heart failure treatment.[Method]Using randomized controlled method,180 cases of hospitalized patients were randomly divided into three groups,the control group,60 cases of conventional treatment.Valsartan Valsartan group of 60 patients 80mg/times,1 times/day,orally,conventional treatment with the control group.Valsartan group,60 cases SMI 25mL +5% glucose injection 100mL infusion,1/d;valsartan,conventional treatment with valsartan group and control group.30d is a course of continuous treatment.Observation of clinical symptoms,cardiac function(stroke volume-SV,cardiac output-CO,ejection fraction-EF),adverse reactions.Continuous treatment of a course of treatment,to determine efficacy.[Results]Clinical valsartan combination group than the control group(P 0.05,P 0.01),the combination group than valsartan group(P 0.05);cardiac function improved in each group(P 0.05,P 0.01),valsartan group and combination group than the control group(P 0.05,P 0.01),the combination group than valsartan group(P 0.05);cardiac function in each group were improved(P 0.05,P 0.01),valsartan group and combination group than the control group(P 0.05,P 0.01),the combination group than valsartan group(P 0.05).[Conclusion]SMI valsartan combined with Western medicine treatment of chronic heart failure,can improve heart function,enhance the effect.